| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |